QuidelOrtho (MEX:QDEL1) Cyclically Adjusted Revenue per Share: MXN1,193.31 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:QDEL1 QuidelOrtho Corp MEX:QDEL1
45 GF Score
Price MXN570.28
GF Value MXN1,583.88
! 8 Warning Signs
View Full Analysis

What is QuidelOrtho Cyclically Adjusted Revenue per Share?

QuidelOrtho MEX:QDEL1 45 Cyclically Adjusted Revenue per Share is MXN1,193.31 as of Jun. 2026. GuruFocus rates MEX:QDEL1 with a GF Score™ of 45/100 and a GF Value™ of MXN1,583.88. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

QuidelOrtho's adjusted revenue per share for the three months ended in Jun. 2026 was MXN161.180. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN1,193.31 for the trailing ten years ended in Jun. 2026.

During the past 12 months, QuidelOrtho's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 16.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 25.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 24.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of QuidelOrtho was 42.90% per year. The lowest was -2.20% per year. And the median was 6.00% per year.

As of today (2026-08-09), QuidelOrtho's current stock price is MXN570.28. QuidelOrtho's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN1,193.31. QuidelOrtho's Cyclically Adjusted PS Ratio of today is 0.48.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of QuidelOrtho was 35.44. The lowest was 0.29. And the median was 5.46.


QuidelOrtho  (MEX:QDEL1) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

QuidelOrtho's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=570.28/1193.31
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of QuidelOrtho was 35.44. The lowest was 0.29. And the median was 5.46.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


QuidelOrtho Cyclically Adjusted Revenue per Share Related Terms


QuidelOrtho Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for QuidelOrtho's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho Cyclically Adjusted Revenue per Share Chart

QuidelOrtho Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 384.19 416.34 405.39 779.18 681.90

QuidelOrtho Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 639.54 646.38 681.90 1,232.19 1,193.31

MEX:QDEL1 vs LMRI, AVNS, TNDM: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, QuidelOrtho's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Cyclically Adjusted PS Ratio falls into.


MEX:QDEL1
45GF Score
QuidelOrtho Corp MEX:QDEL1
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QuidelOrtho Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, QuidelOrtho's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=161.18/333.9520*333.9520
=161.180

Current CPI (Jun. 2026) = 333.9520.

QuidelOrtho Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 29.199 241.428 40.389
201612 33.096 241.432 45.779
201703 40.813 243.801 55.905
201706 20.648 244.955 28.150
201709 27.235 246.819 36.850
201712 65.742 246.524 89.057
201803 73.256 249.554 98.031
201806 53.446 251.989 70.830
201809 51.201 252.439 67.734
201812 60.805 251.233 80.825
201903 66.895 254.202 87.882
201906 50.192 256.143 65.439
201909 57.798 256.759 75.175
201912 66.297 256.974 86.157
202003 94.354 258.115 122.076
202006 106.453 257.797 137.900
202009 241.228 260.280 309.507
202012 369.037 260.474 473.140
202103 176.241 264.877 222.201
202106 82.910 271.696 101.908
202109 246.647 274.310 300.274
202112 296.267 278.802 354.872
202203 470.679 287.504 546.720
202206 233.278 296.311 262.912
202209 233.572 296.808 262.802
202212 252.139 296.797 283.703
202303 227.287 301.836 251.471
202306 170.695 305.109 186.831
202309 193.717 307.789 210.184
202312 188.699 306.746 205.435
202403 176.382 312.332 188.591
202406 173.918 314.175 184.866
202409 212.731 315.301 225.315
202412 218.691 315.605 231.404
202503 209.977 319.799 219.270
202506 170.742 322.561 176.772
202509 188.810 324.800 194.130
202512 191.320 324.054 197.164
202603 163.881 330.213 165.737
202606 161.180 333.952 161.180

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN1,193.31 mean?
QuidelOrtho (MEX:QDEL1) has a Cyclically Adjusted Revenue per Share of MXN1,193.31 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on QuidelOrtho and its competitors.
Is QuidelOrtho's Cyclically Adjusted Revenue per Share too high?
QuidelOrtho's current Cyclically Adjusted Revenue per Share is MXN1,193.31. Overall, QuidelOrtho has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does QuidelOrtho's Cyclically Adjusted Revenue per Share compare to LMRI and AVNS?
QuidelOrtho's Cyclically Adjusted Revenue per Share of MXN1,193.31 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on QuidelOrtho and its competitors. QuidelOrtho's current Cyclically Adjusted Revenue per Share is MXN1,193.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QuidelOrtho stock overvalued right now?
QuidelOrtho (MEX:QDEL1) has a current Cyclically Adjusted Revenue per Share of MXN1,193.31. The stock's GF Value™ is MXN1,583.88, compared to a current price of MXN570.28 — trading 64% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN1,193.31. QuidelOrtho's overall GF Score™ is 45/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For QuidelOrtho (MEX:QDEL1), the current Cyclically Adjusted Revenue per Share is MXN1,193.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is QuidelOrtho (MEX:QDEL1) Overvalued in 2026?

Based on GuruFocus' analysis, QuidelOrtho stock appears to be undervalued. The current stock price of MXN570.28 is trading 64% below its estimated GF Value™ of MXN1,583.88.

Key valuation signals for MEX:QDEL1:

  • Cyclically Adjusted Revenue per Share: MXN1,193.31
  • GF Value™: MXN1,583.88 vs. price of MXN570.28 (64% below fair value)
  • GF Score™: 45/100 with 8 warning signs

No single metric tells the full story. See the MEX:QDEL1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


QuidelOrtho Business Description

Other Exchanges QDEL:USA0A55:UKQL1A:Germany
Address 9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
45GF Score

Get the complete analysis for MEX:QDEL1

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN570.28
Price
MXN1,583.88
GF Value